Release Date: 04/01/22 16:00 Summary: Expiry of Unlisted Options Price Sensitive: No Download Document 123.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%